United States Diagnostic Imaging Market Size, Growth, Latest Trends and Forecast 2025-2033

IMARC Group has recently released a new research study titled “United States Diagnostic Imaging Market Size, Share, Trends and Forecast by Modality, Application, End User, and Region, 2025-2033” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Overview

The United States diagnostic imaging market size was valued at USD 8.2 Billion in 2024 and is expected to reach USD 14.1 Billion by 2033. The market is projected to grow at a CAGR of 6.2% during the forecast period from 2025 to 2033. This growth is driven by technological advancements, an increasing geriatric population, rising chronic disease prevalence, more diagnostic centers, and supportive reimbursement policies.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

United States Diagnostic Imaging Market Key Takeaways

• Current Market Size: USD 8.2 Billion in 2024
• CAGR: 6.2% from 2025 to 2033
• Forecast Period: 2025-2033
• The market is propelled by continuous technological advancements including AI integration and hybrid imaging systems.
• The growing U.S. geriatric population, estimated to reach 82 million by 2050, substantially increases demand for diagnostic imaging.
• Rising prevalence of chronic diseases affects approximately 129 million people, boosting reliance on advanced imaging technologies.
• Emergence of outpatient diagnostic centers offers convenience and cost-effectiveness, complementing hospital services.

Sample Request Link: https://www.imarcgroup.com/united-states-diagnostic-imaging-market/requestsample

United States Diagnostic Imaging Market Growth Factors

Technological Advancements

The United States diagnostic imaging market is significantly driven by ongoing technological progress. Innovations in MRI, CT, and ultrasound technologies have enhanced diagnostic accuracy, safety, and early disease detection. High-resolution imaging now captures complex diseases earlier, enabling timely treatments. The incorporation of artificial intelligence accelerates image analysis and reduces errors, while hybrid imaging systems offer comprehensive functional and anatomical assessments. Portable and miniaturized devices extend diagnostic accessibility beyond hospitals, resulting in improved healthcare delivery and patient outcomes.

Rising Geriatric Population

A key market driver is the rapidly increasing elderly population in the U.S., projected to reach 82 million by 2050, a 47% growth from current figures. The population share aged 65 and older is expected to rise from 17% to 23%. Aging leads to heightened incidences of diseases like arthritis, osteoporosis, and cardiovascular conditions requiring frequent imaging. Approximately 24.3% of adults aged 65 and older reported fair or poor health in 2023, with hypertension rates exceeding 83% among those 75 and older. This demographic shift necessitates expanded imaging infrastructure and technology.

Prevalence of Chronic Diseases

Chronic diseases affect around 129 million Americans, with 42% experiencing multiple conditions, fueling demand for diagnostic imaging. High-detail imaging through CT, MRI, and nuclear medicine supports accurate diagnosis, treatment planning, and monitoring in diseases like cancer, diabetes, and cardiovascular disorders. Early disease detection through advanced imaging improves survival rates and encourages healthcare providers to upgrade imaging services continually to meet growing needs.

Buy Report Now: https://www.imarcgroup.com/checkout?id=20446&method=1190

United States Diagnostic Imaging Market Segmentation

Analysis by Modality:

• MRI 
• Computed Tomography 
• Ultrasound 
• X-Ray 
• Nuclear Imaging 
• Others

Analysis by Application:

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Others

Cardiology uses echocardiography, MRI, and CT angiography to evaluate heart anatomy and function. Oncology employs PET, CT, and MRI to identify tumors and monitor treatment. Neurology mainly uses MRI for detailed brain and spinal cord imaging. Orthopedics relies on X-rays, MRI, and CT to assess musculoskeletal conditions. Gastroenterology employs ultrasound, CT, MRI, and endoscopic ultrasound. Gynecology benefits from 3D and 4D ultrasound for fetal assessment and abnormality detection.

Analysis by End User:

• Hospitals
• Diagnostic Centers
• Others

Hospitals provide comprehensive imaging services with advanced equipment, while diagnostic centers offer fast, cost-effective outpatient imaging. Independent and chain diagnostic centers are expanding technologies like digital X-ray, ultrasound, MRI, and CT scans.

Analysis by Region:

• Northeast
• Midwest
• South
• West

Northeast has numerous advanced medical institutions supporting high demand in cardiology and oncology. Midwest growth is driven by community hospitals and clinics adopting advanced technology. The South experiences increased demand due to chronic disease prevalence. The West, a tech-savvy region, demands AI-integrated and portable imaging devices.

Regional Insights

The Northeast U.S. is the dominant region with a strong presence of advanced medical facilities and academic hospitals. Its aging population drives significant demand for diagnostic imaging in cardiology and oncology specialties. This region's robust healthcare infrastructure supports high utilization of imaging services, contributing significantly to market growth.

Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=20446&flag=C

Recent Developments & News

• In May 2024, United Imaging received FDA clearance for its uMR Jupiter 5T MRI system, the first ultra-high field system cleared for whole body applications.
• In November 2024, Royal Philips obtained FDA 510(k) clearance for its new detector-based Spectral CT 7500 RT, a radiotherapy solution within spectral computed tomography.

Key Players

• United Imaging
• Royal Philips

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302